BASTIDE (EPA:BLC) | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
BASTIDE

PRESS RELEASE

published on 06/09/2025 at 18:15, 5 months 25 days ago

Disposal of CICADUM and MEDSOFT
Bastide Groupe sells French subsidiaries Cicadum and Medsoft specialized in stomatherapy. Transaction to reduce net debt and improve margins. Details on 2024-2025 revenue coming September 4, 2025

Divestment Healthcare Services Revenue Announcement Bastide Groupe Stomatherapy
BRIEF

published on 06/05/2025 at 18:50, 5 months 29 days ago

Sale of Dorge Medic and Dyna Médical by the Bastide Group

Strategy Belgium Bastide Orthopedics Assignment
PRESS RELEASE

published on 06/05/2025 at 18:45, 5 months 29 days ago

Disposal of DORGE and DYNA MEDICAL in Belgium
Bastide Groupe sells Belgian subsidiaries, Dorge Medic and Dyna-Médical, to Aqtor! for €9.6 million revenue, focusing on high-growth businesses. Next: 2024-2025 revenue announcement on Sep 4

Bastide Groupe Belgian Subsidiaries Aqtor! High-growth Businesses 2024-2025 Revenue
BRIEF

published on 06/04/2025 at 18:05, 6 months ago

Baywater strengthens its leading position in respiratory support in the UK

United Kingdom NHS Bastide Group Baywater Respiratory Assistant
PRESS RELEASE

published on 06/04/2025 at 18:00, 6 months ago

Respiratory care therapy: Baywater wins London region tender and consolidates its leading position in the UK
Baywater, a subsidiary of Bastide Groupe, secures exclusive contract to provide respiratory care in London, expanding their UK market share and revenue

UK Market Contract Respiratory Care Bastide Groupe Baywater
BRIEF

published on 06/03/2025 at 18:20, 6 months 1 day ago

BASTIDE: Balance Sheet of Shares and Voting Rights as of May 31, 2025

Share Capital Voting Rights AMF Public Limited Company Bastide Actions
BRIEF

published on 05/15/2025 at 18:05, 6 months 20 days ago

Sustained Growth for Bastide in the 3rd Quarter of 2024-2025

Organic Growth Turnover Bastide Home Health Quarter 2024-2025
PRESS RELEASE

published on 05/15/2025 at 18:00, 6 months 20 days ago

Continued strong organic growth in Q3 2024-2025 at +7.7%: Home healthcare services up 10.4% and recovery of Homecare activities confirmed / 2024-2025 targets confirmed
Bastide Group reports strong third-quarter revenue growth of 7.9% to €144.2 million, with organic growth of 7.7%. Key sectors driving performance include Respiratory and Homecare. 2024-2025 outlook confirms revenue target of at least €560 million and operating margin of 9.1%

Revenue Growth Organic Growth Bastide Group Respiratory Sector 2024-2025 Outlook
BRIEF

published on 05/06/2025 at 18:05, 6 months 29 days ago

BASTIDE: Distribution of Shares and Voting Rights as of April 30, 2025

Share Capital Voting Rights AMF Bastide Actions April 2025
BRIEF

published on 04/02/2025 at 18:05, 8 months 2 days ago

BASTIDE Le Confort Médical: Update on shares and voting rights

Common Shares Voting Rights Financial Markets Authority Preference Shares BASTIDE MEDICAL COMFORT

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 6 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 11 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 41 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 36 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 41 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 41 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 11 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 51 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 16 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 26 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 41 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 56 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 57 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE